Safety and Tolerability of a Wearable, Vibrotactile Stimulation Device for Parkinson’s Disease

Background: Resting tremor is a cardinal symptom of Parkinson’s disease (PD) that contributes to the physical, emotional, and economic burden of the disease.Objective: The goal of this study was to investigate the safety, tolerability, and preliminary effectiveness of a novel wearable vibrotactile s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laura Tabacof, Stephen Braren, Taylor Patterson, Adam Fry, David Putrino
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/acd899691b2c4b6199e679defdd52a91
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:acd899691b2c4b6199e679defdd52a91
record_format dspace
spelling oai:doaj.org-article:acd899691b2c4b6199e679defdd52a912021-11-18T06:50:36ZSafety and Tolerability of a Wearable, Vibrotactile Stimulation Device for Parkinson’s Disease1662-516110.3389/fnhum.2021.712621https://doaj.org/article/acd899691b2c4b6199e679defdd52a912021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnhum.2021.712621/fullhttps://doaj.org/toc/1662-5161Background: Resting tremor is a cardinal symptom of Parkinson’s disease (PD) that contributes to the physical, emotional, and economic burden of the disease.Objective: The goal of this study was to investigate the safety, tolerability, and preliminary effectiveness of a novel wearable vibrotactile stimulation device on resting tremor in individuals with PD.Methods: Using a randomized cross-over design, subjects received two different vibrotactile stimulation paradigms (high amplitude patterned and low amplitude continuous) on two separate laboratory visits. On each visit, resting tremor was video recorded for 10 min at baseline and while the vibrotactile stimulation was applied. Tremor severity was scored by a blinded clinician.Results: Both vibration paradigms were well safe and well tolerated and resulted in a reduction in resting tremor severity with a moderate effect size (n = 44, p < 0.001, r = 0.37–0.54). There was no significant difference between the two vibration paradigms (p = 0.14).Conclusion: Short durations of vibrotactile stimulation delivered via wearable devices were safe and well tolerated and may attenuate resting tremor severity in individuals with PD. The sample size as well as the potential preliminary effectiveness revealed by two arms of the study could not eliminate the potential for a placebo effect.Laura TabacofStephen BrarenTaylor PattersonAdam FryDavid PutrinoFrontiers Media S.A.articleParkinson’s diseaseresting tremorwearable technologiesvibrationUPDRSvibrotactileNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Human Neuroscience, Vol 15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Parkinson’s disease
resting tremor
wearable technologies
vibration
UPDRS
vibrotactile
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Parkinson’s disease
resting tremor
wearable technologies
vibration
UPDRS
vibrotactile
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Laura Tabacof
Stephen Braren
Taylor Patterson
Adam Fry
David Putrino
Safety and Tolerability of a Wearable, Vibrotactile Stimulation Device for Parkinson’s Disease
description Background: Resting tremor is a cardinal symptom of Parkinson’s disease (PD) that contributes to the physical, emotional, and economic burden of the disease.Objective: The goal of this study was to investigate the safety, tolerability, and preliminary effectiveness of a novel wearable vibrotactile stimulation device on resting tremor in individuals with PD.Methods: Using a randomized cross-over design, subjects received two different vibrotactile stimulation paradigms (high amplitude patterned and low amplitude continuous) on two separate laboratory visits. On each visit, resting tremor was video recorded for 10 min at baseline and while the vibrotactile stimulation was applied. Tremor severity was scored by a blinded clinician.Results: Both vibration paradigms were well safe and well tolerated and resulted in a reduction in resting tremor severity with a moderate effect size (n = 44, p < 0.001, r = 0.37–0.54). There was no significant difference between the two vibration paradigms (p = 0.14).Conclusion: Short durations of vibrotactile stimulation delivered via wearable devices were safe and well tolerated and may attenuate resting tremor severity in individuals with PD. The sample size as well as the potential preliminary effectiveness revealed by two arms of the study could not eliminate the potential for a placebo effect.
format article
author Laura Tabacof
Stephen Braren
Taylor Patterson
Adam Fry
David Putrino
author_facet Laura Tabacof
Stephen Braren
Taylor Patterson
Adam Fry
David Putrino
author_sort Laura Tabacof
title Safety and Tolerability of a Wearable, Vibrotactile Stimulation Device for Parkinson’s Disease
title_short Safety and Tolerability of a Wearable, Vibrotactile Stimulation Device for Parkinson’s Disease
title_full Safety and Tolerability of a Wearable, Vibrotactile Stimulation Device for Parkinson’s Disease
title_fullStr Safety and Tolerability of a Wearable, Vibrotactile Stimulation Device for Parkinson’s Disease
title_full_unstemmed Safety and Tolerability of a Wearable, Vibrotactile Stimulation Device for Parkinson’s Disease
title_sort safety and tolerability of a wearable, vibrotactile stimulation device for parkinson’s disease
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/acd899691b2c4b6199e679defdd52a91
work_keys_str_mv AT lauratabacof safetyandtolerabilityofawearablevibrotactilestimulationdeviceforparkinsonsdisease
AT stephenbraren safetyandtolerabilityofawearablevibrotactilestimulationdeviceforparkinsonsdisease
AT taylorpatterson safetyandtolerabilityofawearablevibrotactilestimulationdeviceforparkinsonsdisease
AT adamfry safetyandtolerabilityofawearablevibrotactilestimulationdeviceforparkinsonsdisease
AT davidputrino safetyandtolerabilityofawearablevibrotactilestimulationdeviceforparkinsonsdisease
_version_ 1718424313902661632